Medicare Enrolled
Dr. Ankush Bansal, M.D.
Pain Medicine · Carlsbad, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bansal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bansal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bansal
Dr. Ankush Bansal is a pain medicine specialist in Carlsbad, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Bansal performed 4,394 Medicare services across 1,468 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bansal received a total of $24,382 from 48 pharmaceutical and/or device companies across 419 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bansal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 18% volume in CA
$24,382 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,394
Medicare services
Top 18% in CA for pain medicine
1,468
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~338 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,512 | $101 | $884 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
941 | $0 | $1 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
485 | $60 | $403 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
418 | $235 | $1,600 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
325 | $66 | $608 |
| Injection, methylprednisolone acetate, 40 mg | 137 | $6 | $48 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
112 | $126 | $1,141 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
60 | $88 | $702 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
45 | $159 | $1,161 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
43 | $61 | $456 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
43 | $107 | $875 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
40 | $112 | $741 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
39 | $50 | $409 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
36 | $211 | $1,247 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
34 | $255 | $1,739 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
32 | $110 | $624 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
18 | $458 | $3,091 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
18 | $269 | $1,722 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
15 | $99 | $772 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
15 | $9 | $73 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
14 | $46 | $361 |
| Minimally invasive spine decompression, lower spine A minimally invasive procedure to remove bone from the lower spine to relieve pressure on nerve tissue, guided by imaging and accessed through the skin. |
12 | $476 | $4,225 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$24,382
Total received (2018-2024)
Avg $3,483/year across 7 years
Top 6% in CA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
419
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,853 (56.8%)
Scientific / Research
Research funding and grants
$6,444 (26.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,085 (16.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,819
2023
$1,396
2022
$5,806
2021
$1,702
2020
$781
2019
$6,202
2018
$6,676
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$624
Viseon, Inc.
$337
SPR Therapeutics, Inc
$132
Medtronic, Inc.
$122
Becton, Dickinson and Company
$87
DePuy Synthes Sales Inc.
$80
Collegium Pharmaceutical, Inc.
$66
SI-BONE, INC.
$55
Abbott Laboratories
$51
Nalu Medical, Inc.
$50
PAINTEQ LLC
$49
Curonix LLC
$44
Vertos Medical, Inc.
$39
SCILEX PHARMACEUTICALS INC.
$24
PFIZER INC.
$23
Averitas Pharma Inc.
$21
Nevro Corp.
$15
Top 3 companies account for 60.1% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic USA, Inc.
$9,198
Abbott Laboratories
$2,996
Vertos Medical, Inc.
$2,587
Biohaven Pharmaceutical Holding Company Ltd.
$1,579
Boston Scientific Corporation
$1,525
Nevro Corp.
$1,392
Medtronic, Inc.
$1,065
BOSTON SCIENTIFIC CORPORATION
$613
Viseon, Inc.
$337
SPR Therapeutics, Inc
$335
Stimwave Technologies Incorporated
$306
PAINTEQ LLC
$252
Collegium Pharmaceutical, Inc.
$206
MML US, Inc.
$164
GRT US Holding, Inc.
$121
Flowonix Medical Incorporated
$108
Vertiflex, Inc.
$107
Electronic Waveform Lab, Inc.
$94
Flexion Therapeutics, Inc.
$90
SI-BONE, INC.
$88
Becton, Dickinson and Company
$87
Curonix LLC
$85
Lilly USA, LLC
$83
DePuy Synthes Sales Inc.
$80
Relievant Medsystems, Inc.
$79
Nalu Medical, Inc.
$66
PFIZER INC.
$66
Scilex Pharmaceuticals Inc.
$61
TerSera Therapeutics LLC
$61
Takeda Pharmaceuticals U.S.A., Inc.
$56
BioDelivery Sciences International, Inc.
$49
Hikma Pharmaceuticals USA
$47
Almatica Pharma LLC
$44
Shionogi Inc
$42
SCILEX PHARMACEUTICALS INC.
$38
Masimo Corporation
$37
AbbVie Inc.
$29
SI-BONE, Inc.
$28
Teva Pharmaceuticals USA, Inc.
$24
Zyla Life Sciences
$23
Averitas Pharma Inc.
$21
Neuronetics, Inc.
$21
Zimmer Biomet Holdings, Inc.
$20
Biohaven Pharmaceuticals, Inc.
$19
Piramal Critical Care
$14
INSYS Therapeutics Inc
$14
Pernix Therapeutics Holdings, Inc.
$12
Kaleo, Inc.
$11
Top 3 companies account for 60.6% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AJOVY · Amitiza · Axium INS DRG IPG · BELBUCA · Belbuca · COMIRNATY · DRG IPGs · EMGALITY · ETERNA · EVZIO · GABLOFEN · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GRALISE · General - Pain Management · General - Therapies · IFUSE IMPLANT · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · Kloxxado · LUTONIX Drug Coated Balloon · LYRICA · MaxView System - Lateral Set · NAPRELAN · NEUROSTAR TMS THERAPY SYSTEM · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation-Research Only · OCTRODE · ORTHOVISC · OSTEOCOOL RF ABLATION · Omnia · PAINTEQ · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PROCLAIM · PRODIGY · Patient SafetyNet System · PlasmaBlade · Proclaim Family of SCS IPGs · Proclaim IPG · Prometra II · QUTENZA · Qutenza · RESTORE · ReActiv8 · SCP Bone Substitute · SCS IPGs · SCS leads · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SUBSYS · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w Receiver · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Superion · Superion ISS · Superion Indirect Decompression System · Symproic · TARGETSTIM · UBRELVY · VECTRIS · Vanta · WaveWriter Alpha Prime 16 · XTAMPZA · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (57%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for pain medicine in CA.
Geographic Context
Pain medicines within 10 mi
7
Per 100K population
0.2
County median income
$102,285
Nearest hospital
SCRIPPS MEMORIAL HOSPITAL - ENCINITAS
2.7 mi
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bansal is a clinical cardiology specialist, with above-average Medicare volume (top 18% in CA), with low-engagement industry engagement in the top 6% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bansal experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bansal performed 1,512 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bansal receive payments from pharmaceutical companies?
Yes. Dr. Bansal received a total of $24,382 from 48 companies across 419 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bansal's costs compare to other pain medicines in Carlsbad?
Dr. Bansal's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bansal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Carlsbad
Browse pain medicines in Carlsbad ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in CA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in CA
Which CA pain medicines receive the most from drug and device companies.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Vertos Medical, Inc. Payments to Doctors
See all physicians who received payments from Vertos Medical, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology